Heinrich-Heine University, Duesseldorf Clinical Trials
Sponsors / Heinrich-Heine University, Duesseldorf
The ClinicalTrials.gov registry records 149 trials led by Heinrich-Heine University, Duesseldorf. 28 trials are actively recruiting participants, 2 remain active without open enrollment, and 73 have concluded. 8 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment. The cumulative planned enrollment figure across all listed trials is 41,737 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
149
Total Trials
28
Recruiting
2
Other Active
73
Completed
8
Terminated / Withdrawn
41,737
Total Enrollment
Termination reasons: Other50% · Recruitment50%
Recent Terminations
- Hand-foot Syndrome"It is no longer practicable to complete the trial"
- Colorectal Cancer Metastatic"Slow recruitment."
- Relapsing Remitting Multiple Sclerosis"lack of recruitment"
- Myelodysplastic Syndrome MDS"delayed recruitment"
- Bladder Cancer"delayed recruitment"
- Heparin Induced Thrombocytopenia (HIT)"Supply of Lepirudin ended on 01. April 2012, thus trial terminated on 31. March 2012"
- Hepatocellular Carcinoma
- Fifth Metacarpal Neck Fracture
Active Trials (2 total)
- NCT07273903
- NCT05958706
- NCT07365930
- NCT03539133
- NCT07372820
- NCT07254663
- NCT06313944
- NCT07196176
- NCT06708910
- NCT06586177
- NCT06133543
- Seminoma PHASE2NCT06144736
- NCT06937723
- NCT05848271
- NCT06896227
- Prevention NANCT05813080
- NCT06823570
- NCT06862544
- NCT06820333
- NCT06657131